A new obesity drug that Eli Lilly is researching but hasn't approved is turning up online, even though it's not supposed to be available.
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
Lilly has launched six early-stage clinical programs, and 34 discovery programs with a focus on incretins, amylins, and novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback